Ligand recognition in mu opioid receptor: experimentally based modeling of mu opioid receptor binding sites and their testing by ligand docking. 1996

T Sagara, and H Egashira, and M Okamura, and I Fujii, and Y Shimohigashi, and K Kanematsu
Institute of Synthetic Organic Chemistry, Faculty of Pharmaceutical Sciences, Kyushu University, Fukuoka, Japan.

For three-dimensional understanding of the mechanisms that control potency and selectivity of the ligand binding at the atomic level, we have analysed opioid receptor-ligand interaction based on the receptor's 3D model. As a first step, we have constructed molecular models for the multiple opioid receptor subtypes using bacteriorhodopsin as a template. The S-activated dihydromorphine derivatives should serve as powerful tools in mapping the three-dimensional structure of the mu opioid receptor, including the nature of the agonist-mediated conformational change that permits G protein-coupling to "second messenger' effector molecules, and in identifying specific ligand-binding contacts with the mu opioid receptor. The analyses of the interactions of some opioid ligands with the predicted ligand binding sites are consistent with the results of the affinity labeling experiments.

UI MeSH Term Description Entries
D007082 Ileum The distal and narrowest portion of the SMALL INTESTINE, between the JEJUNUM and the ILEOCECAL VALVE of the LARGE INTESTINE.
D008024 Ligands A molecule that binds to another molecule, used especially to refer to a small molecule that binds specifically to a larger molecule, e.g., an antigen binding to an antibody, a hormone or neurotransmitter binding to a receptor, or a substrate or allosteric effector binding to an enzyme. Ligands are also molecules that donate or accept a pair of electrons to form a coordinate covalent bond with the central metal atom of a coordination complex. (From Dorland, 27th ed) Ligand
D008297 Male Males
D008956 Models, Chemical Theoretical representations that simulate the behavior or activity of chemical processes or phenomena; includes the use of mathematical equations, computers, and other electronic equipment. Chemical Models,Chemical Model,Model, Chemical
D008958 Models, Molecular Models used experimentally or theoretically to study molecular shape, electronic properties, or interactions; includes analogous molecules, computer-generated graphics, and mechanical structures. Molecular Models,Model, Molecular,Molecular Model
D008969 Molecular Sequence Data Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories. Sequence Data, Molecular,Molecular Sequencing Data,Data, Molecular Sequence,Data, Molecular Sequencing,Sequencing Data, Molecular
D011487 Protein Conformation The characteristic 3-dimensional shape of a protein, including the secondary, supersecondary (motifs), tertiary (domains) and quaternary structure of the peptide chain. PROTEIN STRUCTURE, QUATERNARY describes the conformation assumed by multimeric proteins (aggregates of more than one polypeptide chain). Conformation, Protein,Conformations, Protein,Protein Conformations
D001921 Brain The part of CENTRAL NERVOUS SYSTEM that is contained within the skull (CRANIUM). Arising from the NEURAL TUBE, the embryonic brain is comprised of three major parts including PROSENCEPHALON (the forebrain); MESENCEPHALON (the midbrain); and RHOMBENCEPHALON (the hindbrain). The developed brain consists of CEREBRUM; CEREBELLUM; and other structures in the BRAIN STEM. Encephalon
D003198 Computer Simulation Computer-based representation of physical systems and phenomena such as chemical processes. Computational Modeling,Computational Modelling,Computer Models,In silico Modeling,In silico Models,In silico Simulation,Models, Computer,Computerized Models,Computer Model,Computer Simulations,Computerized Model,In silico Model,Model, Computer,Model, Computerized,Model, In silico,Modeling, Computational,Modeling, In silico,Modelling, Computational,Simulation, Computer,Simulation, In silico,Simulations, Computer
D003545 Cysteine A thiol-containing non-essential amino acid that is oxidized to form CYSTINE. Cysteine Hydrochloride,Half-Cystine,L-Cysteine,Zinc Cysteinate,Half Cystine,L Cysteine

Related Publications

T Sagara, and H Egashira, and M Okamura, and I Fujii, and Y Shimohigashi, and K Kanematsu
July 1997, Zhongguo yao li xue bao = Acta pharmacologica Sinica,
T Sagara, and H Egashira, and M Okamura, and I Fujii, and Y Shimohigashi, and K Kanematsu
January 1986, NIDA research monograph,
T Sagara, and H Egashira, and M Okamura, and I Fujii, and Y Shimohigashi, and K Kanematsu
May 2006, Biochemical and biophysical research communications,
T Sagara, and H Egashira, and M Okamura, and I Fujii, and Y Shimohigashi, and K Kanematsu
March 2017, Biochimica et biophysica acta. Proteins and proteomics,
T Sagara, and H Egashira, and M Okamura, and I Fujii, and Y Shimohigashi, and K Kanematsu
January 1997, Acupuncture & electro-therapeutics research,
T Sagara, and H Egashira, and M Okamura, and I Fujii, and Y Shimohigashi, and K Kanematsu
February 2000, Proceedings of the National Academy of Sciences of the United States of America,
T Sagara, and H Egashira, and M Okamura, and I Fujii, and Y Shimohigashi, and K Kanematsu
February 2013, European journal of pharmacology,
T Sagara, and H Egashira, and M Okamura, and I Fujii, and Y Shimohigashi, and K Kanematsu
November 1997, The Journal of biological chemistry,
T Sagara, and H Egashira, and M Okamura, and I Fujii, and Y Shimohigashi, and K Kanematsu
January 2023, Frontiers in pharmacology,
T Sagara, and H Egashira, and M Okamura, and I Fujii, and Y Shimohigashi, and K Kanematsu
April 2002, Regulatory peptides,
Copied contents to your clipboard!